Europe Markets: Technology stocks lead European markets higher as bond yields continue to ease

European stocks climbed on Wednesday, led by the technology sector as bond yields continue to ease up, while earnings rolled in from Akzo Nobel, Aegon and ABN Amro and more.

The Stoxx Europe 600 index SXXP, +1.45% rose 1.4% to 47, following a 0.7% gain on Tuesday. The German DAX DAX, +1.46% rose 1.4%, the French CAC 40 PX1, +1.45% rose 1.5% and the FTSE 100 index UKX, +0.67% was up 0.6%. The euro EURUSD, +0.08% and pound GBPUSD, +0.16% were little changed.

The bond market has been the center of action lately as investors weigh up possible interest-rate rises around the world. Perceived hawkish comments from European Central Bank President Christine Lagarde have driven up the euro in recent days. The 10-year German bund yield TMBMKDE-10Y, 0.216% was down 3 basis points to 0.231%, while Italy’s 10-year bond TMBMKIT-10Y, 1.775% fell 4 basis points to 1.79%.

The bigger focus this week will fall on U.S. consumer-price inflation for Thursday as a Federal Reserve meeting and expected interest-rate hike looms for March. U.S. stock futures YM00, +0.56% ES00, +0.68% NQ00, +0.81% pointed to a higher open for Wall Street as the 10-year Treasury note TMUBMUSD10Y, 1.916% yield also fell.

Data from Germany showed a rise in exports for December, but at slower pace than imports, statistics office Destatis said Wednesday.

Interest-rate sensitive tech stocks were getting a lift on easing bond yields, with shares of ASML Holding ASML, +0.53% up 2.6%, ASM International ASM, +4.46% up 2.6% and AMS-Osram AMS, +3.53% up 3.7%.

Several stocks were reacting to earnings news. Shares of Ayden ADYEN, +10.10% led the gainers, with shares up 11%, after the Dutch payments group reported a forecast-beating 62% rise in second-half net profit and an upbeat view.

Pandora stock PNDORA, +6.84% climbed nearly 6%, after the Danish jeweler proposed a new 3.3 billion Danish kroner ($506.2 million) share buyback and said its current performance remains solid, with continued profit growth. After preleasing fourth-quarter figures last month, Pandora said organic growth was 23% in January.

On the other end, shares of Aegon AGN, -4.60% tumbled 5%. The Dutch insurance and asset-management company reported a significant rise in net profit for the fourth quarter of 2021, which came in above market views, and said it continues to reduce its expenses. However, analysts zeroed in on results that they saw as mixed and conservative guidance from the group.

Also reporting was Akzo Nobel AKZO, +0.32%, whose shares got a 3% lift after the Dutch paints company announced plans for a new 500 million euro ($570.9 million) share-buyback program after reporting a market-beating net profit for the fourth quarter of the year.

Siemens Energy ENR, +2.33% shares rose 1.5%, after the German energy company swung to a net loss for the quarter ended Dec. 31, and reported an 11% fall in revenue, though that was in line with a warning from the company last month. That followed a profit warning from its subsidiary Siemens Gamesa Renewable Energy.

GlaxoSmithKline shares GSK, -0.07% GSK, +0.51% were up 0.5%. The COVID-19 vaccine maker posted a rise in final-quarter 2021 net profit that came short of a company-provided consensus, but sales beat expectations. Glaxo said it expects to deliver sales growth in 2022 of between 5% to 7% at constant exchange rates.

The pharmaceutical giant also said the demerger of its consumer healthcare business was on track to happen in mid-2022.

Source

Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.